Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glutathionylspermidine disulfide is an experimental small molecule belonging to the class of oligopeptides. It is a dimeric disulfide form of glutathionylspermidine, a conjugate of glutathione and spermidine. This compound plays a crucial role in cellular redox balance and antioxidant defense, particularly in trypanosomes[7]. In humans, it interacts with mitochondrial glutathione reductase (GSR), which maintains high levels of reduced glutathione in the cytosol[1]. Glutathionylspermidine disulfide has been studied as a substrate for trypanothione reductase and is primarily used as a research tool rather than for therapeutic purposes[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glutathionylspermidine disulfide.